City of Hope (Duarte)

Clinical research site in San Francisco, California

As of July 2026, 1 paid clinical trial is recruiting at City of Hope (Duarte) in San Francisco, California. Active studies at this site focus on Triple Negative Breast Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at City of Hope (Duarte) (1)

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

124 locations incl. Birmingham

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

More research sites in San Francisco

University of California, San Francisco (321 trials)
University of California San Francisco (163 trials)
Power Life Sciences (61 trials)
UCSF Medical Center-Mission Bay (38 trials)
UCSF (34 trials)
Kaiser Permanente-San Francisco (34 trials)
Zuckerberg San Francisco General Hospital (25 trials)
UCSF Helen Diller Family Comprehensive Cancer Center (23 trials)
UCSF Medical Center (22 trials)
California Pacific Medical Center-Pacific Campus (21 trials)

Explore more

Paid clinical trials in San Francisco, CA · California clinical trials